Despite weak evidence, spinal cord stimulators are big business

A Cochrane for Clinicians article in the December 2023 issue of American Family Physician reviewed randomized trials assessing the effectiveness of surgically implanted spinal cord stimulation devices for the treatment of chronic low back pain. These devices come with a high price tag ($30,000) and potential complications that include electrode migratio…